CN113795268B - 治疗眼疾的方法 - Google Patents
治疗眼疾的方法 Download PDFInfo
- Publication number
- CN113795268B CN113795268B CN202080025566.3A CN202080025566A CN113795268B CN 113795268 B CN113795268 B CN 113795268B CN 202080025566 A CN202080025566 A CN 202080025566A CN 113795268 B CN113795268 B CN 113795268B
- Authority
- CN
- China
- Prior art keywords
- diabetic retinopathy
- eye
- thickness
- administration
- beauvericin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/15—Depsipeptides; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Ophthalmology & Optometry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962828616P | 2019-04-03 | 2019-04-03 | |
| US62/828,616 | 2019-04-03 | ||
| US201962899279P | 2019-09-12 | 2019-09-12 | |
| US62/899,279 | 2019-09-12 | ||
| PCT/CN2020/082765 WO2020200241A1 (en) | 2019-04-03 | 2020-04-01 | Method for treating ocular diseases |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN113795268A CN113795268A (zh) | 2021-12-14 |
| CN113795268B true CN113795268B (zh) | 2025-04-08 |
Family
ID=72662774
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202080025566.3A Active CN113795268B (zh) | 2019-04-03 | 2020-04-01 | 治疗眼疾的方法 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US11033603B2 (enExample) |
| EP (1) | EP3946414B1 (enExample) |
| JP (1) | JP7461663B2 (enExample) |
| CN (1) | CN113795268B (enExample) |
| SG (1) | SG11202110659SA (enExample) |
| TW (1) | TWI818168B (enExample) |
| WO (1) | WO2020200241A1 (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI788083B (zh) * | 2021-11-03 | 2022-12-21 | 葡萄王生技股份有限公司 | 蟬花菌絲體活性物質用於治療黃斑部病變之用途 |
| US20240316144A1 (en) * | 2023-03-20 | 2024-09-26 | ZIH YUAN TANG Biotechnology Co, Ltd. | Pharmaceutical composition and method for inhibiting angiogenesis |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0327316A (ja) * | 1989-06-23 | 1991-02-05 | Kitasato Inst:The | 高脂血症治療剤 |
| BRPI0615974A2 (pt) * | 2005-07-27 | 2011-05-31 | University Of Florida Research Foundation, Inc., | uso de choque térmico para tratar uma doença ocular em um indivìduo, método para recrutar uma célula-tronco para um tecido ocular de um indivìduo com necessidade da mesma, uso de choque térmico para tratar uma doença ou um distúrbio ocular em um indivìduo com necessidade do mesmo, uso de choque térmico para regenerar a retina em um indivìduo com necessidade do mesmo, uso de choque térmico para reparar os danos ao epitélio pgmentar da retina em um indivìduo com necessidade do mesmo, uso de choque térmico para tratar a degeneração macular em um indivìduo com necessidade do mesmo, composição farmacêutica para o recrutamento de células-tronco, composição farmacêutica para recrutamento de células-tronco em um tecido ocular, kit e método para identificar um agente que aumenta o recrutamento de células-tronco em um tecido ocular |
| CN101669939A (zh) * | 2009-09-22 | 2010-03-17 | 中山大学 | 恩镰孢菌素类化合物在制备抗耐药结核菌药物中的应用 |
| US20140275091A1 (en) * | 2013-03-15 | 2014-09-18 | Coyote Pharmaceuticals, Inc. | Ocular formulations comprising geranylgeranylacetone derivatives for intraocular delivery |
| US20140371158A1 (en) * | 2013-06-14 | 2014-12-18 | Georgia Regents University | Beauvericin compositions and methods thereof for inhibiting the hsp90 chaperone pathway |
| CN109200066A (zh) * | 2017-07-07 | 2019-01-15 | 葡萄王生技股份有限公司 | 蝉花活性物质及其用于预防、延缓或治疗白内障的用途 |
-
2020
- 2020-04-01 JP JP2021560499A patent/JP7461663B2/ja active Active
- 2020-04-01 SG SG11202110659SA patent/SG11202110659SA/en unknown
- 2020-04-01 WO PCT/CN2020/082765 patent/WO2020200241A1/en not_active Ceased
- 2020-04-01 CN CN202080025566.3A patent/CN113795268B/zh active Active
- 2020-04-01 TW TW109111356A patent/TWI818168B/zh active
- 2020-04-01 US US16/837,259 patent/US11033603B2/en active Active
- 2020-04-01 EP EP20782491.3A patent/EP3946414B1/en active Active
Non-Patent Citations (1)
| Title |
|---|
| 白僵菌素对支气管哮喘模型小鼠气道炎症的影响及其机理研究;吴刚;朱佳;朱际平;;江苏中医药;20170605(第06期);摘要 * |
Also Published As
| Publication number | Publication date |
|---|---|
| US11033603B2 (en) | 2021-06-15 |
| EP3946414A1 (en) | 2022-02-09 |
| CA3132137A1 (en) | 2020-10-08 |
| JP7461663B2 (ja) | 2024-04-04 |
| WO2020200241A1 (en) | 2020-10-08 |
| EP3946414B1 (en) | 2025-12-03 |
| CN113795268A (zh) | 2021-12-14 |
| KR20210149087A (ko) | 2021-12-08 |
| JP2022528566A (ja) | 2022-06-14 |
| TW202102252A (zh) | 2021-01-16 |
| TWI818168B (zh) | 2023-10-11 |
| US20200316165A1 (en) | 2020-10-08 |
| EP3946414A4 (en) | 2022-12-07 |
| EP3946414C0 (en) | 2025-12-03 |
| SG11202110659SA (en) | 2021-10-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Massin et al. | Intravitreal triamcinolone acetonide for diabetic diffuse macular edema: preliminary results of a prospective controlled trial | |
| Audren et al. | Intravitreal triamcinolone acetonide for diffuse diabetic macular edema: phase 2 trial comparing 4 mg vs 2 mg | |
| Miyake | Prevention of cystoid macular edema after lens extraction by topical indomethacin (I) A preliminary report | |
| Suto et al. | A novel dual agonist of EP3 and FP receptors for OAG and OHT: safety, pharmacokinetics, and pharmacodynamics of ONO-9054 in healthy volunteers | |
| US8097640B2 (en) | Prophylactic or therapeutic agent for diabetic maculopathy | |
| TWI818168B (zh) | 治療眼疾的方法 | |
| KOLLARITS et al. | Norepinephrine therapy of ischemic optic neuropathy | |
| CA3132137C (en) | Method for treating ocular diseases | |
| JP4578593B2 (ja) | 糖尿病性網膜症治療のためのスロデキサイドを含有する医薬 | |
| Shin et al. | Intraocular Pressure-denpendent Retinal Vascular Change in Adult Chronic Open-angle Glaucoma Patients | |
| Ozdemir et al. | Comparison of the intraocular pressure lowering effect of latanoprost and carteolol-pilocarpine combination in newly diagnosed glaucoma | |
| Schilling et al. | An elusive case of cystoid macular edema | |
| Rolando et al. | Cyclosporine pharmacokinetics in healthy volunteers after ocular administration of OTX-101, a novel nanomicellar cyclosporine formulation | |
| EP3331517B1 (fr) | Utilisation d'hydroxycarbamide pour prevenir la non-perfusion retinienne | |
| WO2024090606A1 (ko) | 후공막염의 치료방법 | |
| Nowak et al. | Protective effect on visual functions of long-term use of trimetazidine in treatment of primary open angle glaucoma and degenerative myopia | |
| RU2356520C1 (ru) | Способ лечения постконтузионного повреждения сетчатки глаза | |
| WO2024193256A1 (zh) | 一种白殭菌素用于制备抑制血管新生药物的用途 | |
| Farag et al. | Study of Structural Changes in Diabetic Macular Edema by Spectral Domain Optical Coherent Tomography after Intravitreal Injection of Triamcinolone Acetonide | |
| Rhee et al. | The effects of Bendaline (R) on cataracts. | |
| Cameron et al. | DIABETIC RETINOPATHY AND CYANCOBALAMIN (VITAMIN B12): A PRELIMINARY REPORT | |
| Sanabria et al. | Atypical myopic retinoschisis | |
| Mohsen Abou Shousha et al. | Comparative Study of Intravitreal Ranibizumab with and Without Nepafenac Eye Drops for Center Involving Diabetic Macular Edema | |
| JP2021134176A (ja) | ムーコル症治療薬 | |
| Upadhyay et al. | Efficiency of Fenofibrate in Facilitating the Reduction of Central Macular Thickness in Diabetic Macular Edema |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant |